EP2829290A1 — Drive unit for a drug delivery device
Assigned to Sanofi Aventis Deutschland GmbH · Expires 2015-01-28 · 11y expired
What this patent protects
Described is a drive unit (1) for a drug delivery device comprising a carrier (3), a plunger (4) arranged within the carrier (3) and slidable in a direction of a longitudinal axis (A), a drive spring (5) arranged for biasing the plunger (4) in a distal direction (D) relative the …
USPTO Abstract
Described is a drive unit (1) for a drug delivery device comprising a carrier (3), a plunger (4) arranged within the carrier (3) and slidable in a direction of a longitudinal axis (A), a drive spring (5) arranged for biasing the plunger (4) in a distal direction (D) relative the carrier (3), and a drive force adaption mechanism (22) for modifying a force exerted by the drive spring (5) on the plunger (4).
Drugs covered by this patent
- Ozempic (semaglutide) · Novo Nordisk
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.